Arnatar Therapeutics
Making Dual-Regulation RNA Clear and Undeniable
The challenge: Create clarity around groundbreaking science
Arnatar’s dual-regulation RNA platform—capable of siRNA-based downregulation and gene upregulation—was scientifically groundbreaking but hard to grasp quickly for investors and potential BD partners–a must in this fast-paced biotech environment. Arnatar needed a website refresh that would make the potential of their platform science clear, the brand credible, and ensure that the launch-week PR landed with confidence. And they needed it fast.
Our Role
- Brand strategy
- Brand identity
- UX/UI Design
- Development
Industry
- Biotech & Life Science
Our approach: clarity and focus
Clarity, first.
We distilled a complex scientific concept into a clear platform story anyone could follow. A short discovery sprint combined ecosystem and messaging analysis to nail how to explain the dual-regulation advantage.
Design intentionality.
Arnatar’s visual language was completely rebuilt. We defined levels of visual fidelity—from attention-grabbers to mechanism-of-action diagrams—and set clear animation e early, allowing for scroll-guided storytelling that stayed within scope.
Lifecycle fluency.
We replaced the standard pipeline graphic with a modular component that can flex as Arnatar grows—communicating progress, partnerships, and programs without rebuilds.
Partnership mindset.
Weekly touchpoints, transparent rate-limiting steps, and one decisive client lead kept decisions fast and alignment tight. Every stage was framed so internal stakeholders could see (and defend) the process.
What we delivered
- Discovery, ecosystem, and messaging analysis
- Palette, type, and imagery refresh
- Scientific illustration system with defined fidelity levels
- Modular, accessible pipeline design
- Content template that let the client “write to structure”
- Responsive UI and build with tight design–dev loops
Proof of impact / Client-reported results
- Huge increase in LinkedIn engagement following launch.
- Perception shift: “Ok, Now I get it” – from investors regarding upregulation.
- Cited by the client as a major driver of launch-week credibility.
“We did have some big business objectives … I think the end product really hit a lot of those things home…”
Why it worked
- A decisive, empowered client who trusted the process.
- System-minded design and development that trimmed complexity early.
- Clear messaging that bridged the gap between science and business.
Get In Touch
We are full of ideas, we just need someone to share them with.
